Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-11,900
Closed -$389K – 13149
2025
Q4
$389K Sell
11,900
-2,400
-17% -$59K ﹤0.01% 9355
2025
Q3
$255K Buy
+14,300
New +$207K ﹤0.01% 10485
2025
Q2
– Sell
-29,400
Closed -$544K – 12633
2025
Q1
$544K Buy
+29,400
New +$531K ﹤0.01% 8718
2021
Q3
– Sell
-18,100
Closed -$391K – 12719
2021
Q2
$391K Sell
18,100
-1,700
-9% -$34.4K ﹤0.01% 10188
2021
Q1
$401K Hold
19,800
– – ﹤0.01% 9979
2020
Q4
$354K Buy
+19,800
New +$291K ﹤0.01% 8946
2019
Q4
– Sell
-70,600
Closed -$881K – 9691
2019
Q3
$881K Buy
+70,600
New +$1.16M ﹤0.01% 5952
2019
Q1
– Sell
-42,200
Closed -$862K – 8800
2018
Q4
$862K Sell
42,200
-10,100
-19% -$316K ﹤0.01% 4966
2018
Q3
$1.93M Buy
+52,300
New +$2.28M ﹤0.01% 4062
2017
Q2
– Sell
-11,300
Closed -$118K – 9169
2017
Q1
$118K Buy
+11,300
New +$115K ﹤0.01% 8318

Other funds holding AXGN

Jeff Yass's AXGN Position: Q3 2026 in Review

Jeff Yass increased its Axogen (AXGN) stake by 963% in Q3 2026, buying an estimated $4.94M and bringing the position to 121,438 shares worth $5.09M. The position accounts for ﹤0.01% of the portfolio, ranked #4405.

Jeff Yass first reported a position in AXGN in Q1 2016 and has held it in 26 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q3 2026.

  • Jeff Yass held 121,438 shares of Axogen worth $5.09M as of Q3 2026.
  • Jeff Yass bought 110,009 Axogen shares in Q3 2026, an estimated $4.94M.
  • Axogen made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4405 holding.
  • Jeff Yass first reported a position in Axogen in Q1 2016 and has held it in 26 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.